Akari Therapeutics's total assets for Q3 2025 were $45.38M, a decrease of -10.87% from the previous quarter. AKTX total liabilities were $22.69M for the fiscal quarter, a -10.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.